FDA revokes emergency use authorization for chloroquine and hydroxychloroquine
- Details
- Category: FDA

Global regulators commit to cooperate on observational research in the context of COVID-19
- Details
- Category: EMA

FDA takes new actions to accelerate development of novel prevention, treatment options for COVID-19
- Details
- Category: FDA

FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment
- Details
- Category: FDA

FDA reiterates importance of close patient supervision for 'off-label' use of antimalarial drugs
- Details
- Category: FDA

FDA encourages recovered patients to donate plasma for development of blood-related therapies
- Details
- Category: FDA

FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19
- Details
- Category: FDA

More Pharma News ...
- FDA Continues to Accelerate Development of Novel Therapies for COVID-19
- The FDA is facilitating access to convalescent plasma collected from recovered COVID-19 patients
- FDA continues to facilitate development of COVID-19 treatments
- FDA and FTC warn seven companies selling fraudulent products that claim to treat or prevent COVID-19
- FDA approves new treatment for adults with Cushing's disease
- FDA approves first generic of Daraprim
- FDA takes action with Indian Government to protect consumers from illicit medical products